A dietary and behavioral intervention designed to lower coronary heart disease. Risk factors are unaffected by variation at the APOE gene locus

Atherosclerosis

Volumn 132, Issue 2, 1997, Pages 221-227

  Pasagian Macaulay, Araxi ^a,b   Aston, Christopher E ^a   Ferrell, Robert E ^a   McAllister, Andrea E ^a   Wing, Rena R ^a   Kuller, Lewis H ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b NONE   (United States)

Author keywords

Apo E lipoprotein; Cholesterol; Premenopausal; Weight

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BEHAVIOR MODIFICATION; BODY WEIGHT; CONTROLLED STUDY; CORONARY RISK; DIET THERAPY; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; NORMAL HUMAN; PREMENOPAUSE; PRIORITY JOURNAL;

APOLIPOPROTEINS E; CORONARY DISEASE; DIETARY FATS; EXERCISE; FEMALE; HUMANS; MIDDLE AGED; PREMENOPAUSE; RISK FACTORS;

EID: 0030757272     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00091-9     Document Type: Article

References (46)

1. Boerwinkle E, Utermann G. Simultaneous effects of the apo E polymorphism on apo E, apo B, and cholesterol metabolism. Am J Hum Genet 1988;42:104-12.
2. Mahley RW, Innerarity TL. Lipoprotein receptors and cholesterol homeostasis. Biochem Biophys Acta 1983;737:197-222.
3. Brown MS, Goldstein JL. Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic. J Clin Invest 1983;72:743-7.
4. Brown MS, Goldstein JL. The receptor model for transport of cholesterol in plasma. Ann New York Acad Sci 1985;454:172-82.
5. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 1986;232:34-47.
6. Scott J, Knott TJ, Shaw DJ, Brook JD. Localization of genes encoding apolipoproteins cl, Cll, and E to the p13 cen region of human chromosome 19. Hum Genet 1985;71:144-6.
7. Weisgraber KH, Rall SC, Mahiley RW. Human E apolipoprotein heterogeneity. Cysteine-arginine interchanges in the aminoacid sequence of the apoE isoform. J Biol Chem 1981;256:9077-83.
8. Menzel HJ, Kladetzky RG, Assman G. Apo E polymorphism and coronary artery disease. Arteriosclerosis 1983;3:310-5.
9. Sing CF, Davignon J. Role of the apo E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 1985;37:268-85.
10. Lenzen HJ, Assman G, Buchwalsky R, Schulte H. Association of apo E polymorphism, LDLc and coronary artery disease. Clin Chem 1986;32:778-81.
11. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21.
12. Hixson JE. Apolipoprotein E polymorphisms affect atheriosclerosis in young males: pathobiological determinants of atheriosclerosis in youth (PDAY) research group. Arterioscler Thromb 1991;11:1237-44.
13. Eichner JE, Kuller LH, Orchard TJ, et al. Relation of APOE phenotype to myocardial infarction and mortality from CAD. AJC 1993;71:160-5.
14. Pairitz Jarvick G, Austin MA, Fabsitz RR, Auwerx TR, Christian JC, Deeb S. Genetic influences on age related change in total cholesterol, LDLc and triglyceride levels: longitudinal apo E genotype effects. Gen Epidemiol 1994;11:375-84.
15. Stengard JH, Zerba KE, Pekkanen J, Ehnholm C, Nissinen A, Sing CF. Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation 1995;91:265-9.
16. Wilson PWF, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer EJ. Apolipoprotein E alles, dyslipidemia, and coronary heart disease. JAMA 1995;272:1666-71.
17. Demant T, Bedford D, Packard CJ, Shepard J. Influence of apo E polymorphism on apo B-100 metabolism in normolipemic subjects. J Clin Invest 1991;88:1490-501.
18. Miettinen TA, Gylling H, Vanhanen H. Serum cholesterol response to dietary cholesterol and apo E phenotype. Lancet 1988;2:1261.
19. Tikkanen MJ, Huttunen JK, Enholm C, Pietinen P. Apo E4 homozygosity predisposes to serum cholesterol elevation during high fat diet. Arteriosclerosis 1990;10:285-8.
20. Clifton PM, Kestin M, Abbey M, Drysdale M, Nestel PJ. Relationship between sensitivity to dietary fat and dietary cholesterol. Arteriosclerosis 1990;10:394-401.
21. Manttari M, Kosninen P, Enholm C, Huttunen JK, Manninen V. Apo E polymorphism influences the serum cholesterol response to dietary intervention. Metabolism 1991;40:217-21.
22. Weisffeld JL, Holloway JJ. Precision of blood cholesterol measurement and high blood cholesterol measurements and high blood cholesterol casefinding and treatment. J Clin Epidemiol 1992;45:971-84.
23. Lehtimaki T, Moilanen T, Solakivi T, Laippala P, Ehnholm C. Cholesterol-rich diet induced changes in plasma lipids in relation to apo E phenotype in health students. Ann Med 1992;24:61-6.
24. Murakami K, Shimizu M, Yamada N, et al. Apo E polymorphism is associated with plasma cholesterol response in a 7-day hospitalization study for metabolic and dietary control in NIDDM. Diabetes Care 1993;16:564-9.
25. Denke MA, Grundy SM. Individual responses to a cholesterol-lowering diet in 50 men with moderate hypercholesterolemia. AIM 1994;154:317-25.
26. Lopez-Miranda J, Ordovas JM, Mata P, et al. Effect of apo E phenotype on diet-induced lowering of plasma LDLc. J Lipid Res 1994;35:1965-75.
27. Dreon DM, Fernstrom HA, Miller B, Krauss RM. Apolipoprotein E isoform phenotype and LDL subclass response to a reduced-fat diet. Arterioscler Thromb Vasc Bioi 1995;15:105-11.
28. Fisher EA, Blum CB, Zannis VI, Breslow JL. Independent effects of dietary saturated fat and cholesterol on plasma lipids, lipoproteins, and apolipoprotein E. J Lipid Res 1983;24(1):1039-48.
29. Boerwinkle E, Brown SA, Rohrbach K, Gotto AM Jr., Patsch W. Role of Apo E and B gene variation in determining response of lipid, lipoprotein, and apolipoprotein levels to increased dietary cholesterol. Am J Hum Genet 1991;49:1145-54.
30. Glatz JFC, Demacker PNM, Turner PR, Katan MB. Response of serum cholesterol to dietary cholesterol in relation to apo E phenotype. Nutr Metab Cardiovasc Dis 1991;2:13-7.
31. Savolainen MJ, Rantala K, Kervinen L, et al. Magnitude of dietary effects on plasma cholesterol concentration: role of sex and apo E phenotype. Atherosclerosis 1991;80:145-52.
32. Cobb MM, Teitlebaum H, Rissch J, Jekel J, Otsfeld A. Influence of dietary fat, apo E phenotype, and sex on plasma lipoprotein levels. Circulation 1992;86:849-57.
33. Martin W, Connelly PW, Nancoo D, et al. Cholesterol ester transfer protein and high density lipoprotein responses to cholesterol feeding in men: relationship to apo E genotype. J Lipid Res 1993;34:437-46.
34. Eichner JE, Kuller LH, Ferrell RE, Meilahn EN, Kamboh MI. Phenotypic effects of apolipoproteon structural variation on lipid profiles. III. Contribution of apoE phenotype variation to prediction of total cholesterol, apoB, and LDLc in the Healthy Women Study. Arteriosclerosis 1990;10:379-85.
35. Matthews KA, Meilahn E, Kuller LH, Kelsey SF, Caggiula AW, Wing RR. Menopause and risk factors for coronary heart disease. N Engl J Med 1989;321:641-6.
36. Wing RR, Matthews KA, Kuller LH, Meilahn EN, Plantigua PL. Weight gain at the time of menopause. Arch Intern Med 1991;151:97-102.
37. Simkin Silverman L, Wing RR, Hansen DH, et al. Prevention of cardiovascular risk factor elevations in healthy premenopausal women. Prev Med 1995;24:509-17.
38. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
39. Hixson JE, Vernier DT. Restriction isotyping of human apoE by gene amplification and cleavage with Hhal. J Lipid Res 1990;30:545-8.
40. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-5.
41. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem 1972;18:499-503.
42. Shapiro SS, Wilk MB. An analysis of variance test for normality (complete samples). Biometrika 1965;52:591-611.
43. Templeton AR. The general relationship between average effect and average excess. Genet Res 1987;49:69.
44. Boerwinkle E, Sing CF. Bias of the contribution of single-locus effects to the variance of a quantitative trait. Am J Hum Genet 1986;39:137.
45. Kaprio J, Ferrell RE, Kottke B, Kamboh MI, Sing CF. Effect of polymorphisms in apolipoproteins E, A-IV and H on quantitative traits related to risk for cardiovasculardisease. Arterioscler Thromb 1991;11:1330-48.
46. Shaefer EJ, Lamon-Sava S, Johnson S, et al. Effects of gender and menopausal status on the association of APOE phenotypes with plasma lipoprotein levels: results from the Framingham Offspring Study. Arterioscler Thromb 1994;14:1105-13.